Homocysteine, white matter lesions and brain atrophy: The smart-MR study von Risselada, R, Appelman, A.P.A, van der Graaf, Y, Vincken, K.L, Witkamp, T.D, Tiehuis, A.M, Mali, W.P.T.M, Geerlings, M.I

Volltext

A phase II/III trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma: The STELLAR study von Brahm, C.G., van Linde, M.E., Labots, M., Kouwenhoven, M.C.M., Sanchez Aliaga, E., Enting, R.H., Appelman, A.P.A., Nuver, J., Walenkamp, A.M.E., Verheul, H.M.W.

Volltext

436TiP - A phase II/III trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma: The STELLAR study von Brahm, C.G., van Linde, M.E., Labots, M., Kouwenhoven, M.C.M., Sanchez Aliaga, E., Enting, R.H., Appelman, A.P.A., Nuver, J., Walenkamp, A.M.E., Verheul, H.M.W.

Volltext

Combined Effect of Cerebral Hypoperfusion and White Matter Lesions on Executive Functioning – The SMART-MR Study von Appelman, A.P.A., van der Graaf, Y., Vincken, K.L., Mali, W.P.T.M., Geerlings, M.I.

Volltext

Brain atrophy in patients with arterial disease. The SMART-MR study von Appelman, A.P.A

Volltext bestellen